Targeting mTOR Shows Promise in Cutaneous Sarcoidosis

Vienna researchers reported that 7 of 10 patients treated with systemic sirolimus had noted improvements in skin lesions, which continued for up to 2 years of follow-up.
Medscape Medical News

source https://www.medscape.com/viewarticle/targeting-mtor-shows-promise-cutaneous-sarcoidosis-2024a100024b?src=rss

Comments

Popular posts from this blog

DC’s Harllee Harper Is Using Public Health Tools to Prevent Gun Violence. Will It Work?